565 related articles for article (PubMed ID: 25637141)
1. N-methyl-D-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in children.
Wright S; Hacohen Y; Jacobson L; Agrawal S; Gupta R; Philip S; Smith M; Lim M; Wassmer E; Vincent A
Arch Dis Child; 2015 Jun; 100(6):521-6. PubMed ID: 25637141
[TBL] [Abstract][Full Text] [Related]
2. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.
Irani SR; Bera K; Waters P; Zuliani L; Maxwell S; Zandi MS; Friese MA; Galea I; Kullmann DM; Beeson D; Lang B; Bien CG; Vincent A
Brain; 2010 Jun; 133(Pt 6):1655-67. PubMed ID: 20511282
[TBL] [Abstract][Full Text] [Related]
3. Clinical presentation of anti-N-methyl-d-aspartate receptor and anti-voltage-gated potassium channel complex antibodies in children: A series of 24 cases.
Konuskan B; Yildirim M; Topaloglu H; Erol I; Oztoprak U; Tan H; Gocmen R; Anlar B
Eur J Paediatr Neurol; 2018 Jan; 22(1):135-142. PubMed ID: 29153996
[TBL] [Abstract][Full Text] [Related]
4. Update on anti-N-methyl-D-aspartate receptor encephalitis in children and adolescents.
Florance-Ryan N; Dalmau J
Curr Opin Pediatr; 2010 Dec; 22(6):739-44. PubMed ID: 21045695
[TBL] [Abstract][Full Text] [Related]
5. Anti-N-methyl-d-aspartate receptor encephalitis in children: Incidence and experience in Hong Kong.
Ho AC; Chan SH; Chan E; Wong SS; Fung ST; Cherk SW; Fung EL; Ma KH; Tsui KW; Yau EK; Wong VC
Brain Dev; 2018 Jun; 40(6):473-479. PubMed ID: 29599011
[TBL] [Abstract][Full Text] [Related]
6. Anti-NMDAR autoimmune encephalitis.
Miya K; Takahashi Y; Mori H
Brain Dev; 2014 Sep; 36(8):645-52. PubMed ID: 24211006
[TBL] [Abstract][Full Text] [Related]
7. N-methyl-D-aspartate receptor antibody-associated movement disorder without encephalopathy.
Hacohen Y; Dlamini N; Hedderly T; Hughes E; Woods M; Vincent A; Lim M
Dev Med Child Neurol; 2014 Feb; 56(2):190-3. PubMed ID: 24127856
[TBL] [Abstract][Full Text] [Related]
8. Analysis of relapses in anti-NMDAR encephalitis.
Gabilondo I; Saiz A; Galán L; González V; Jadraque R; Sabater L; Sans A; Sempere A; Vela A; Villalobos F; Viñals M; Villoslada P; Graus F
Neurology; 2011 Sep; 77(10):996-9. PubMed ID: 21865579
[TBL] [Abstract][Full Text] [Related]
9. Auto-immune anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis: three case reports.
Bashiri FA; Al-Rasheed AA; Hassan SM; Hamad MHA; El Khashab HY; Kentab AY; AlBadr FB; Salih MA
Paediatr Int Child Health; 2017 Aug; 37(3):222-226. PubMed ID: 27329512
[TBL] [Abstract][Full Text] [Related]
10. Anti-N-methyl-d-aspartate receptor encephalitis in children of Central South China: Clinical features, treatment, influencing factors, and outcomes.
Wang Y; Zhang W; Yin J; Lu Q; Yin F; He F; Peng J
J Neuroimmunol; 2017 Nov; 312():59-65. PubMed ID: 28935354
[TBL] [Abstract][Full Text] [Related]
11. Anti-N-methyl-D-aspartate receptor encephalitis: a newly recognized inflammatory brain disease in children.
Luca N; Daengsuwan T; Dalmau J; Jones K; deVeber G; Kobayashi J; Laxer RM; Benseler SM
Arthritis Rheum; 2011 Aug; 63(8):2516-22. PubMed ID: 21547896
[TBL] [Abstract][Full Text] [Related]
12. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.
Dalmau J; Gleichman AJ; Hughes EG; Rossi JE; Peng X; Lai M; Dessain SK; Rosenfeld MR; Balice-Gordon R; Lynch DR
Lancet Neurol; 2008 Dec; 7(12):1091-8. PubMed ID: 18851928
[TBL] [Abstract][Full Text] [Related]
13. N-methyl-D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse.
Hacohen Y; Deiva K; Pettingill P; Waters P; Siddiqui A; Chretien P; Menson E; Lin JP; Tardieu M; Vincent A; Lim MJ
Mov Disord; 2014 Jan; 29(1):90-6. PubMed ID: 24014096
[TBL] [Abstract][Full Text] [Related]
14. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.
Titulaer MJ; McCracken L; Gabilondo I; Armangué T; Glaser C; Iizuka T; Honig LS; Benseler SM; Kawachi I; Martinez-Hernandez E; Aguilar E; Gresa-Arribas N; Ryan-Florance N; Torrents A; Saiz A; Rosenfeld MR; Balice-Gordon R; Graus F; Dalmau J
Lancet Neurol; 2013 Feb; 12(2):157-65. PubMed ID: 23290630
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of 71 cases of anti-N-methyl-D-aspartate receptor encephalitis in children].
Wang GL; Yin F; Wang Y; Zhang WX; He F; Yang LF; Wu LW; Peng J
Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):125-130. PubMed ID: 30695887
[No Abstract] [Full Text] [Related]
16. Immunotherapy for anti-NMDA receptor encephalitis: Experience from a single center in Taiwan.
Kong SS; Chen YJ; Su IC; Lin JJ; Chou IJ; Chou ML; Hung PC; Hsieh MY; Wang YS; Chou CC; Wang HS; Lin KL;
Pediatr Neonatol; 2019 Aug; 60(4):417-422. PubMed ID: 30449706
[TBL] [Abstract][Full Text] [Related]
17. N-methyl-D-aspartate receptor encephalitis: laboratory diagnostics and comparative clinical features in adults and children.
Gastaldi M; Nosadini M; Spatola M; Sartori S; Franciotta D
Expert Rev Mol Diagn; 2018 Feb; 18(2):181-193. PubMed ID: 29376438
[TBL] [Abstract][Full Text] [Related]
18. [Anti-N-methyl-D-aspartate receptor encephalitis in seven children].
Wang XH; Fang F; Ding CH; Lü JL; Han TL; Liu LY; Li JW; Wu Y; Cui LY; Ren HT; Xu CL
Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):885-9. PubMed ID: 23324141
[TBL] [Abstract][Full Text] [Related]
19. Assessing the incidence of anti-NMDAR encephalitis.
Greene M; Lancaster E
Arch Dis Child; 2015 Jun; 100(6):512-3. PubMed ID: 25809344
[No Abstract] [Full Text] [Related]
20. Clinical characteristics of anti
Zheng J; Shen J; Wang A; Liu L; Xiong J; Li X; Xiao Y; Li J; Mao D; Liu L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jan; 45(1):47-54. PubMed ID: 32132297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
